Intrauterine Device Versus Uterine Artery Embolization for Adenomyosis

Launched by YONSEI UNIVERSITY · Sep 12, 2023

Keywords

ClinConnect Summary

This clinical trial is comparing two treatments for women with adenomyosis, a condition where the tissue that normally lines the uterus grows into the uterine wall, causing symptoms like heavy or painful periods. The study is looking at how well an intrauterine device (IUD) works compared to a procedure called uterine artery embolization. This trial is currently recruiting women aged 19 to 48 who are experiencing significant symptoms and have a low hemoglobin level, which means they might be anemic.

To participate, women must not have any current infections, blood clotting disorders, or other serious conditions like cancer or endometriosis, and they should not be pregnant. If eligible, participants can expect to receive one of the two treatments and will be monitored to see how well each option helps with their symptoms. This research aims to provide valuable information that could help other women with similar conditions in the future.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • 1. Women with symptomatic fibroids (age: 19 - 48 years old) 2. Hemglobin \< 12g/dL, 3. Symptoms of adenomysis (Menorrhagia, Dysmenorrhea)
• Exclusion Criteria:
• • 1. Gynecologic malignancy 2. Ongoing infection or inflammation 3. Coagulopathy (platelet \< 50,000 or INR \> 1.5) 4. Concomitant endometriosis 5. Pregnancy